查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1225280

前列腺癌治疗市场：2023-2028 年全球行业趋势、份额、规模、增长、机遇和预测

Prostate Cancer Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2022 年全球前列腺癌治疗市场规模将达到 72 亿美元。 展望未来，IMARC Group 预计到 2028 年将达到 103 亿美元，2023 年至 2028 年的增长率 (CAGR) 为 5.8%。

前列腺癌是男性前列腺内各种异常细胞不受控制地分裂扩张而引起的一种严重恶性肿瘤。 它可以通过使用各种治疗方法来治疗，包括疫苗、药物和治疗。 化学疗法、免疫疗法、冷冻疗法、手术、激素疗法、靶向疗法和放射疗法是阻止癌细胞在体内扩散的最常见疗法。 这些治疗是根据各种评估向患者提供的，包括患者的年龄、症状的严重程度、医疗状况和既往健康史。

前列腺癌药物市场趋势

  • 前列腺癌的患病率不断上升，尤其是在老年人群中，这是目前推动市场增长的主要因素之一。 与此同时，有利的医疗报销政策和各国政府机构推出患者援助计划 (PAP) 的众多举措也是推动增长的因素。 PAP 是由製药公司管理的一项有组织的计划，通过免费提供用于治疗目的的药物来为患者提供经济援助。 此外，在早期检测前列腺癌的同时减少诊断错误，包括将多参数磁共振成像 (mp-MRI) 设备与非转移性去势抵抗 (nmCRPC) 和转移性激素天然 (mHNPC) 设置相结合 重大技术进步在製造领域也为市场增长做出了贡献。 此外，大力投资研发活动以推出新的治疗产品，以及各种线上和线下分销渠道的便捷供应，为市场创造了光明的前景。

主要市场细分

  • IMARC Group 分析了全球前列腺癌治疗市场报告每个子细分市场的主要趋势，并提供了 2023 年至 2028 年全球、区域和国家层面的预测。 该报告根据药物类型和销售渠道对市场进行分类。

按药物类型细分

  • 化疗
  • 生物疗法
  • 激素疗法
  • 其他

按销售渠道细分

  • 医院药房
  • 药店和零售店
  • 在线药店

按地区划分

  • 北美
  • 美国
  • 加拿大
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳大利亚
  • 印度尼西亚
  • 其他
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 意大利
  • 西班牙
  • 俄罗斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中东和非洲

内容

第一章前言

第 2 章研究方法和范围

  • 调查的目的
  • 利益相关者
  • 数据来源
    • 主要信息
    • 次要信息
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章执行摘要

第四章介绍

  • 概览
  • 主要行业趋势

第 5 章全球前列腺癌治疗市场

  • 市场概览
  • 市场结果
  • COVID-19 的影响
  • 市场预测

第 6 章按药物类型划分的市场细分

  • 化疗
    • 市场趋势
    • 市场预测
  • 生物製剂
    • 市场趋势
    • 市场预测
  • 激素疗法
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第 7 章分销渠道市场细分

  • 医院药房
    • 市场趋势
    • 市场预测
  • 药店/药房
    • 市场趋势
    • 市场预测
  • 在线药店
    • 市场趋势
    • 市场展望

第 8 章按区域划分的市场细分

  • 北美
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场展望
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场展望
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场展望
    • 韩国市场
      • 市场趋势
      • 市场展望
    • 澳大利亚
      • 市场趋势
      • 市场展望
    • 印度尼西亚
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场展望
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场展望
    • 西班牙
      • 市场趋势
      • 市场展望
    • 俄罗斯
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场展望
    • 墨西哥
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家/地区划分的市场细分
    • 市场展望

第9章SWOT分析

  • 概览
  • 强度
  • 弱点
  • 机会
  • 威胁

第 10 章价值链分析

第11章波特五力分析

  • 概览
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章竞争格局

  • 市场结构
  • 主要公司
  • 主要公司简介
    • Astellas Pharma Inc.
    • AstraZeneca plc
    • Bayer Aktiengesellschaft
    • Dendreon Pharmaceuticals LLC.（Sanpower Group Co. Ltd.）
    • F. Hoffmann-La Roche AG
    • Ferring B.V.
    • GlaxoSmithKline Plc
    • Ipsen（Mayroy SA）
    • Novartis International AG
    • Takeda Pharmaceutical Company Ltd.
    • Tolmar Pharmaceuticals Inc.
Product Code: SR1423A121_Report

The global prostate cancer treatment market size reached US$ 7.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.

Prostate cancer is a type of severe malignant tumor, which is caused by the uncontrollable division and expansion of various abnormal cells in the prostate gland present in men. It can be treated through the use of various therapeutics, such as vaccines, medications, and treatments. Amongst these, chemotherapy, immunotherapy, cryotherapy, surgery, hormonal, targeted and radiation therapy are some of the most common treatment types that aid in mitigating the spread of cancer cells in the body. These therapies are provided to the patient based on various assessments, such as the age of the patient, severity of the symptoms experienced, medical condition, and previous health history.

Prostate Cancer Treatment Market Trends:

  • The increasing prevalence of prostate cancer, especially amongst the rising geriatric population, is one of the prime factors currently driving the market toward growth. In line with this, the availability of favorable medical reimbursement policies and the numerous initiatives being undertaken by the government bodies of several countries for introducing patient assistance programs (PAPs) are acting as other growth-inducing factors. PAP is an organized program, which is controlled by pharmaceutical companies for providing financial assistance to patients by offering free medications for treatment purposes. Moreover, significant technological advancements, such as the integration of multiparametric-magnetic resonance imaging (mp-MRI) devices with non-metastatic castration-resistant (nmCRPC) and metastatic hormone nave (mHNPC) settings for detecting prostate cancer at early stages, while mitigating diagnostic errors, is also contributing to the market growth. Additionally, extensive investments in the research and development (R&D) activities to introduce novel therapeutic products, along with their easy availability across various online and offline distribution channels, are creating a positive outlook for the market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global prostate cancer treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug type and distribution channel.

Breakup by Drug Type:

  • Chemotherapy
  • Biological Therapy
  • Hormone Therapy
  • Others

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., AstraZeneca plc, Bayer Aktiengesellschaft, Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.), F. Hoffmann-La Roche AG, Ferring B.V., GlaxoSmithKline Plc, Ipsen (Mayroy SA), Novartis International AG, Takeda Pharmaceutical Company Ltd. and Tolmar Pharmaceuticals Inc.
  • Key Questions Answered in This Report
  • 1. What was the size of the global prostate cancer treatment market in 2022?
  • 2. What is the expected growth rate of the global prostate cancer treatment market during 2023-2028?
  • 3. What are the key factors driving the global prostate cancer treatment market?
  • 4. What has been the impact of COVID-19 on the global prostate cancer treatment market?
  • 5. What is the breakup of the global prostate cancer treatment market based on drug type?
  • 6. What is the breakup of the global prostate cancer treatment market based on the distribution channel?
  • 7. What are the key regions in the global prostate cancer treatment market?
  • 8. Who are the key players/companies in the global prostate cancer treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Prostate Cancer Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Chemotherapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biological Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hormone Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospitals Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Drug Stores and Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Astellas Pharma Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 AstraZeneca plc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bayer Aktiengesellschaft
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Ferring B.V.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 GlaxoSmithKline Plc
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Ipsen (Mayroy SA)
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Novartis International AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Takeda Pharmaceutical Company Ltd.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Tolmar Pharmaceuticals Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Prostate Cancer Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Prostate Cancer Treatment Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Prostate Cancer Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Prostate Cancer Treatment Market: Breakup by Drug Type (in %), 2022
  • Figure 5: Global: Prostate Cancer Treatment Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Prostate Cancer Treatment Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Prostate Cancer Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Prostate Cancer Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Prostate Cancer Treatment (Biological Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Prostate Cancer Treatment (Biological Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Prostate Cancer Treatment (Hormone Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Prostate Cancer Treatment (Hormone Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Prostate Cancer Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Prostate Cancer Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Prostate Cancer Treatment (Hospitals Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Prostate Cancer Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Prostate Cancer Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Prostate Cancer Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Prostate Cancer Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Prostate Cancer Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: North America: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: North America: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: United States: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: United States: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Canada: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Canada: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Asia-Pacific: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Asia-Pacific: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: China: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: China: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Japan: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Japan: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: India: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: India: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: South Korea: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: South Korea: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Australia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Australia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Indonesia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Indonesia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Europe: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Europe: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Germany: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Germany: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: France: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: France: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: United Kingdom: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: United Kingdom: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Italy: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Italy: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Spain: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Spain: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Russia: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Russia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Latin America: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Latin America: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Brazil: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Brazil: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Mexico: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Mexico: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Others: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Middle East and Africa: Prostate Cancer Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Middle East and Africa: Prostate Cancer Treatment Market: Breakup by Country (in %), 2022
  • Figure 69: Middle East and Africa: Prostate Cancer Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Global: Prostate Cancer Treatment Industry: SWOT Analysis
  • Figure 71: Global: Prostate Cancer Treatment Industry: Value Chain Analysis
  • Figure 72: Global: Prostate Cancer Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Prostate Cancer Treatment Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Prostate Cancer Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
  • Table 3: Global: Prostate Cancer Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 4: Global: Prostate Cancer Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Prostate Cancer Treatment Market: Competitive Structure
  • Table 6: Global: Prostate Cancer Treatment Market: Key Players